Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 131

1.
3.

Cell-mediated immunity to Epstein-Barr virus and a blocking factor in patients with infectious mononucleosis.

Lai PK, Mackay-Scollay EM, Fimmel PJ, Alpers MP, Keast D.

Nature. 1974 Dec 13;252(5484):608-10. No abstract available.

PMID:
4372559
4.
5.

Cellular immunity in infectious mononucleosis. II. Specific reactivity to Epstein-Barr Virus antigens and correlation with clinical and hematologic parameters.

Nikoskelainen J, Ablashi DV, Isenberg RA, Neel EU, Miller RG, Stevens DA.

J Immunol. 1978 Oct;121(4):1239-44.

PMID:
81224
7.

Epstein-Barr virus (EBV) antigen-specific leukocyte migration inhibition (LMI) in infectious mononucleosis (IM). I. Kinetics and response to a membrane protein on EBV-transformed cells.

Szigeti R, Timar L, Weiland O, Henle W, Henle G, Hennessy K, Kieff E, Sulitzeanu D, Dillner J, Klein G.

Clin Immunol Immunopathol. 1986 Dec;41(3):342-50.

PMID:
3022972
8.

The MLC response of patients with infectious mononucleosis to Epstein-Barr virus-transformed cells.

Wasik M, Myc A, Matej H, Rudzka L.

Arch Immunol Ther Exp (Warsz). 1983;31(6):871-8.

PMID:
6331340
9.

Epstein-Barr virus (EBV) antigen-specific leukocyte migration inhibition in infectious mononucleosis. II. Kinetics of sensitization against five EBV-encoded nuclear proteins and the latent membrane protein.

Szigeti R, Kallin B, Dillner J, Henle G, Henle W, Lerner RA, Rymo L, Timar L, Klein G.

Clin Immunol Immunopathol. 1989 Jun;51(3):396-405.

PMID:
2470542
11.
12.

Lymphocyte reactivity in infectious mononucleosis.

ten Napel CH, The TH.

J Infect Dis. 1980 Jun;141(6):716-23.

PMID:
6248602
13.

[Leukocyte migration inhibition elicited by Epstein-Barr virus antigen. Reaction potential in infectious mononucleosis as well as in states of immune deficiency and immunosuppression].

Szigeti R, Klein E, Masucci MG, Ernberg I, Masucci G, Svedmyr E, Klein G.

Orv Hetil. 1982 May 16;123(20):1217-21. Hungarian. No abstract available.

PMID:
6287380
14.

Cell mediated immunity during infectious mononucleosis to Epstein-Barr virus associated antigens.

Periman P, Levine PH, Ablashi DV, Royston I.

Int J Cancer. 1977 Oct 15;20(4):506-11.

PMID:
199544
15.

Immune response to intermediate filament-associated, Epstein-Barr virus-induced early antigen.

Sairenji T, Nguyen QV, Woda B, Humphreys RE.

J Immunol. 1987 Apr 15;138(8):2645-52.

PMID:
2435803
16.

Leukocyte migration inhibition with Epstein-Barr virus negative and positive cell extracts.

Szigeti R, Timár L, Révész T.

Allergy. 1980 Mar;35(2):97-103.

PMID:
6155797
17.

Epstein Barr virus-specific immune defects in patients with persistent symptoms following infectious mononucleosis.

Borysiewicz LK, Haworth SJ, Cohen J, Mundin J, Rickinson A, Sissons JG.

Q J Med. 1986 Feb;58(226):111-21.

PMID:
3012622

Supplemental Content

Support Center